|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0022341,
umls-concept:C0023418,
umls-concept:C0023467,
umls-concept:C0034656,
umls-concept:C0677908,
umls-concept:C0750729,
umls-concept:C1257890,
umls-concept:C1511484,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-14
|
|
pubmed:abstractText |
A major concern in the treatment of patients with acute myeloid leukemia (AML) is how to prevent disease recurrences. Although intensive consolidation therapy has proven useful, the effectiveness of maintenance therapy remains controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AsouNorioN,
pubmed-author:EmiNobuhikoN,
pubmed-author:HondaSumihisaS,
pubmed-author:JanesMandyM,
pubmed-author:KishimotoYujiY,
pubmed-author:MatsudaShinS,
pubmed-author:MatsushimaTakafumiT,
pubmed-author:MitaniKinukoK,
pubmed-author:MiyawakiShuichiS,
pubmed-author:MiyazakiYasushiY,
pubmed-author:OgawaYoshiakiY,
pubmed-author:OhnoRyuzoR,
pubmed-author:OhtakeShigekiS,
pubmed-author:SakamakiHisashiH,
pubmed-author:TakahashiMasatomoM,
pubmed-author:YagasakiFumiharuF
|
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2726-34
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16284985-6-Mercaptopurine,
pubmed-meshheading:16284985-Adolescent,
pubmed-meshheading:16284985-Adult,
pubmed-meshheading:16284985-Aged,
pubmed-meshheading:16284985-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16284985-Cytarabine,
pubmed-meshheading:16284985-Daunorubicin,
pubmed-meshheading:16284985-Disease-Free Survival,
pubmed-meshheading:16284985-Dose-Response Relationship, Drug,
pubmed-meshheading:16284985-Drug Administration Schedule,
pubmed-meshheading:16284985-Female,
pubmed-meshheading:16284985-Follow-Up Studies,
pubmed-meshheading:16284985-Humans,
pubmed-meshheading:16284985-Idarubicin,
pubmed-meshheading:16284985-Leukemia, Myeloid, Acute,
pubmed-meshheading:16284985-Male,
pubmed-meshheading:16284985-Middle Aged,
pubmed-meshheading:16284985-Mitoxantrone,
pubmed-meshheading:16284985-Probability,
pubmed-meshheading:16284985-Remission Induction,
pubmed-meshheading:16284985-Risk Assessment,
pubmed-meshheading:16284985-Treatment Outcome,
pubmed-meshheading:16284985-Vincristine,
pubmed-meshheading:16284985-Vindesine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
|
|
pubmed:affiliation |
Division of Hematology, Saiseikai Maebashi Hospital, Maebashi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
